NF-kB plays a preponderant role in CRC development and progression, also reported to promote resistance to chemo- and radio- therapies, thus marking itself an interesting therapeutic target for treatment of cancer and demands further investigation [32]. This evidence concerns the gene NFKB1 and colorectal carcinoma.